Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Novus_Therapeutics
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:developedBy |
gptkb:AT-1501
|
| gptkbp:focus |
neurodegenerative diseases
immunotherapy |
| gptkbp:foundedBy |
gptkb:ALS_Therapy_Development_Institute
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anelixis Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Boston,_Massachusetts
|
| gptkbp:website |
https://anelixis.com
|
| gptkbp:bfsParent |
gptkb:Novus_Therapeutics
|
| gptkbp:bfsLayer |
7
|